Haixiang Pharmaceutical: The application for the listing of its affiliated company Huayi Taikang on the Beijing Stock Exchange has been accepted

2026-04-04 02:12:26

Abstract generation in progress

Daily Economic News AI Express, on April 1, Hai Xiang Pharmaceutical (002099.SZ) announced that the company recently received a notice from its investee company Hua Yi Tai Kang. Hua Yi Tai Kang’s application to publicly issue shares to unspecified qualified investors and to list on the Beijing Stock Exchange has been formally accepted by the Beijing Stock Exchange. As of the date of disclosure of this announcement, the company holds 1.112 million shares of Hua Yi Tai Kang, accounting for 1.85% of the total share capital. Hua Yi Tai Kang’s listing application still needs to obtain the Beijing Stock Exchange’s approval of its review, as well as the decision of the China Securities Regulatory Commission to approve the registration. Whether it can ultimately be successful remains uncertain. The company will promptly fulfill its information disclosure obligations in accordance with the progress of the matter.

Daily Economic News

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.